Dr. Joseph J. Buggy, Ph.D., is Vice President Research of Pharmacyclics, Inc., since September 2007. From May 2006 to August 2007, Dr. Buggy served as Senior Director, Research at Pharmacyclics. From November 2001 to April 2006, he served as Director, Department of Biology at Celera Genomics, a biotechnology company. From June 1996 to October 2001, he was a staff scientist at AXYS Pharmaceuticals, Inc., a biotechnology company. Prior to that Dr. Buggy worked as a scientist at Bayer Corporationrationration in West Haven, CT
Vice President - Research
Age: 45 President Since 2007 Ph.D
|Buggy received a Ph.D. in Molecular, Cellular, and Developmental Biology from Indiana University and a B.S. degree in Microbiology from the University of Pittsburgh.|
The company has return on total asset (ROA) of 31.72 % which means that it generated profit of $31.72 on every $100 spent on asset. This is very large. Similarly, it shows return on stockholders equity (ROE) of 66.49 % meaning that it created $66.49 on every $100 dollars invested by stockholders.
Entity SummaryPharmacyclics, Inc., a clinicalstage biopharmaceutical company, focuses on the development and commercialization of smallmolecule drugs for the treatment of cancer and immune mediated diseases. Pharmacyclics Inc [PCYC] is traded on Nasdaq Capital Markets in USA. It is located in Sunnyvale, CA and employs 247 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| PCYC Nasdaq
Pharmacyclics Inc has more than 78.4 (%) percent chance of experiencing financial distress in the next 2 years of operations.
PCYC price boundaries
Promote PCYC and Joseph Buggy